Close X
 
 

Sweet combination


The patient who changed the way I think about diabetes

 
 
 
 

What can you do when a patient has good glycaemic control but high CVD risk? Dr Marc Evans on a case that highlights the need for real-world evidence evaluation of combination therapy using GLP-1 receptor agonists and SGLT-2 inhibitors.

 
WP_Post Object ( [ID] => 26892 [post_author] => 4 [post_date] => 2021-03-01 10:12:15 [post_date_gmt] => 2021-03-01 10:12:15 [post_content] => [post_title] => Metabolic surgery [post_excerpt] => [post_status] => publish [comment_status] => closed [ping_status] => closed [post_password] => [post_name] => metabolic-surgery [to_ping] => [pinged] => [post_modified] => 2021-06-15 09:51:55 [post_modified_gmt] => 2021-06-15 08:51:55 [post_content_filtered] => [post_parent] => 0 [guid] => https://easd-elearning.org/?post_type=sfwd-courses&p=26892 [menu_order] => 0 [post_type] => sfwd-courses [post_mime_type] => [comment_count] => 0 [filter] => raw )
Launching soon
Metabolic surgery
More like this